Today Jun 14, 2021
Event Image
Back to Events

An Overview of CLL and the Use of a Targeted Agent for Previously Untreated or R/R CLL

Wednesday Jul 07, 2021
Event Time 12:15 - 12:45 PM ET
Register Now
Event Faculty

Nilanjan Ghosh, MD

Chief of Lymphoma Division
Levine Cancer Institute
New Hyde Park, NY

This program presents clinical efficacy and safety data supporting the use of a selective Bruton tyrosine kinase inhibitor for the treatment of previously untreated and R/R CLL 

Event Sponsors